Press Releases
-
January 26, 2021
WVU Medicine Selects Omnicell One Intelligence Solution to Drive Better Pharmacy Inventory Management, Optimize Costs, and Support Better Patient Care
Partnership to Optimize Enterprise Medication Inventory Management Across the Health System Jan. 26, 2021- Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies,...
-
January 13, 2021
Omnicell Announces Preliminary Fiscal Year 2020 Financial Results
Company Expects to Exceed Previously Announced Guidance Across All Key Metrics; Provides Full Year 2021 Guidance and Updates Long-Term Targets 2020 Total Product Bookings Expected to be Approximately $1.00 Billion and 2020 Revenues Expected to be...
-
January 11, 2021
Omnicell's EnlivenHealth™ Reports Strong Customer Demand for New SaaS Technology Solution to Help Pharmacies Meet COVID-19 Vaccination Challenges
CareScheduler Automates Vaccine Scheduling, Consent Collection, Registry Reporting and Patient Outreach; Enables Pharmacies to Efficiently Administer COVID-19 Vaccine Jan. 11, 2021- Omnicell, Inc., (Nasdaq:OMCL), a leading provider of medication...
-
January 04, 2021
Omnicell to Partner with Guy’s and St Thomas’ NHS Foundation Trust, London on Development of European Technology-Enabled Intelligence Centre as Part of Expansion of Omnicell Systems Across the South East London NHS Integrated Care System
Jan. 4, 2021- Omnicell, Inc. (Nasdaq: OMCL), a leading provider of medication management and supply chain solutions for health systems, today announced its intent to enter a new partnership with Guy’s and St Thomas’ NHS Foundation Trust , London to...
-
December 21, 2020
Owensboro Health to Deploy Omnicell’s Technology-Enabled Services to Improve Safety and Efficiency in Medication Management
Partnership Extends Medication Management Platform to Central Pharmacy Operations Dec. 21, 2020- Omnicell, Inc. (Nasdaq: OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today...
-
December 15, 2020
Omnicell to Present at the J.P. Morgan 39th Annual Healthcare Conference
Dec. 15, 2020- Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, announced its participation in the following upcoming investor conferences: Randall Lipps,...
-
November 11, 2020
New National Survey Finds the Majority of Retail Pharmacies and Health Plans Are Concerned About People Actually Taking the COVID-19 Vaccine Once It’s Available
EnlivenHealth™ Launches CareScheduler Solution to Enable Pharmacies to Provide Hands-Free Scheduling, Consent and Registry Reporting for COVID-19 Vaccine, Reducing Infection Risk for Patients and Staff Nov. 11, 2020- EnlivenHealth™, a division of...
-
November 10, 2020
Omnicell Announces Latest Advancements in Automation, Intelligence, and Technology-Enabled Services at Omnicell Illuminate 2020
Winter 2020 Release Delivers Innovation to Support the Autonomous Pharmacy Journey to Zero-Error Medication Management Nov. 10, 2020- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for health...
-
November 09, 2020
Allegheny Health Network Partners with Omnicell to Drive Safety and Efficiency for Medication Management Across Western Pennsylvania Network
Nov. 9, 2020- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management and supply chain solutions for health systems, today announced a new partnership with Allegheny Health Network (AHN), to provide central pharmacy dispensing and...
-
October 27, 2020
Omnicell Reports Third Quarter 2020 Results
GAAP and non-GAAP revenues of $213.7 million GAAP net income per diluted share of $0.20 Non-GAAP net income per diluted share of $0.60 Oct. 27, 2020- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence...
-
October 22, 2020
Lehigh Valley Health Network Chooses Omnicell Solutions to Enhance Clinical and Operational Outcomes and Streamline Medication Management
Represents Omnicell’s 142nd Long-Term Partnership with a Top 300 US Health System Oct. 22, 2020- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today...
-
October 20, 2020
Memorial Hospital at Gulfport Selects Omnicell Central Pharmacy Dispensing Service to Enhance Medication Safety and Dispensing Efficiency
Combination of automation and technology-enabled services supports more cost-effective workflows and expanded distribution models Oct. 20, 2020- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools...
-
October 06, 2020
Omnicell Launches EnlivenHealth™ to Aid Retail Pharmacies and Health Plans In Improving Patient Adherence, Quality Measures, and Retention
The Industry-Leading Engagement and Digital Communication Solutions from EnlivenHealth Aim to Achieve Lifelong Optimal Health for Patient Populations Oct. 6, 2020- Omnicell, Inc., (NASDAQ:OMCL), a leading provider of medication management solutions...
-
October 01, 2020
Omnicell Completes Acquisition of Pharmaceutical Strategy Group’s Leading 340B Software-Enabled Service Business
Expands pharmacy inventory management capabilities for efficient, compliant management of 340B programs Accelerates Omnicell’s strategic transformation to support the vision of the fully Autonomous Pharmacy, building on the recent launch of Omnicell...
-
September 29, 2020
Omnicell to Release Third Quarter 2020 Earnings Results on October 27, 2020
Sep. 29, 2020- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Tuesday, October 27, 2020 , to discuss the Company’s Third...
-
September 23, 2020
Omnicell, Inc. Prices $500 Million 0.25% Convertible Senior Notes Offering (up 37.5% Conversion Premium)
Sep. 23, 2020- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, announced today the pricing of $500 million aggregate principal amount of 0.25%...
Previous